Association of interleukin-8 (IL-8 or CXCL8) -251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer

Neoplasma

Volumn 54, Issue 6, 2007, Pages 484-489

  Kamali Sarvestani, E ^a,b   Aliparasti, M R ^a   Atefi, S ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; CXCR2; IL 8; Polymorphism

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; INTERLEUKIN 8;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; BREAST TUMOR; CASE CONTROL STUDY; DISEASE COURSE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PAGET NIPPLE DISEASE; POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-8; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-8B;

EID: 38949135757     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. MANTOVANI A. The chemokine system: redundancy for robust outputs. Immunol Today 1999; 20: 254-257.
2. ROEBUCK KA. Regulation of interleukin-8 gene expression. J Interferon Cytokine Res 1999; 19: 429-438.
3. XIE K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 2001; 12: 375-391.
4. BAGGIOLINI M, DEWALD B, MOSER B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 1994; 55: 97-179. (Pubitemid 124006545)
5. MARTINEZ FO, SIRONI M, VECCHI A, et al. IL-8 induces a specific transcriptional profile in human neutrophils: synergism with LPS for IL-1 production. Eur J Immunol 2004; 34: 2286-2292.
6. BAGGIOLINI M, LOETSCHER P. Chemokines in inflammation and immunity. Immunol Today 2000; 21: 418-420.
7. RICHMOND A, AND THOMAS HG. Purification of melanoma growth stimulatory activity. J Cell Physiol 1986; 129: 375-384.
8. GALFFY G, MOHAMMED KA, DOWLING PA, et al. Interleukin 8: an autocrine growth factor for malignant mesothelioma. Cancer Res 1999; 59: 367-371. (Pubitemid 29048869)
9. XU L, AND FIDLER IJ. Interleukin 8: an autocrine growth factor for human ovarian cancer. Oncol Res 2000; 12: 97-106.
10. TAKAMORI H, OADES ZG, HOCH OC, et al. Autocrine growth effect of IL-8 and GROalpha on a human pancreatic cancer cell line, Capan-1. Pancreas 2000; 21: 52-56.
11. RICHARDS BL, EISMA RJ, SPIRO JD, et al. Co expression of interleukin-8 receptors in head and neck squamous cell carcinoma. Am J Surg 1997; 174: 507-512. (Pubitemid 27486015)
12. FUJIMOTO J, SAKAGUCHI H, AOKI I, et al. Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers. Cancer Res 2000; 60: 2632-2635.
13. NURNBERG W, TOBIAS D, OTTO F, et al. Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma. J Pathol 1999; 189: 546-551.
14. RETZLAFF S, PADRO T, KOCH P, et al. Interleukin 8 and Flt3 ligand as markers of advanced disease in primary gastrointestinal non-Hodgkin's lymphoma. Oncol Rep 2002; 9: 525-527.
15. ORDITURA M, DE VITA F, CATALANO G, et al. Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: relationship with prognosis. J Interferon Cytokine Res 2002; 22: 1129-1135. (Pubitemid 36051185)
16. BENOY IH, SALGADO R, VAN DAM P, et al. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin Cancer Res 2004; 10: 7157-7162. (Pubitemid 39487700)
17. STRIETER RM, POLVERINI PJ, KUNKEL SL, et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995; 270: 27348-27357.
18. SALCEDO R, MARTINS-GREEN M, GERTZ B, et al. Combined administration of antibodies to human interleukin 8 and epidermal growth factor receptor results in increased anti metastatic effects on human breast carcinoma xenografts. Clin Cancer Res 2002; 8: 2655-2665.
19. DE LARCO JE, WUERTZ BR, ROSNER KA, et al. A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells. Am J Pathol 2001; 158: 639-646.
20. PALKOWETZ KH, ROYER CL, GAROFALO R, et al. Production of interleukin-6 and interleukin-8 by human mammary gland epithelial cells. J Reprod Immunol 1994; 26: 57-64. (Pubitemid 24091967)
21. ADDISON CL, DANIEL TO, BURDICK MD, et al. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J Immunol 2000; 165: 5269-5277.
22. AHUJA SK, MURPHY PM. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem 1996; 271: 20545-20550.
23. MILLER LJ, KURTZMAN SH, WANG Y, et al. Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue. Anticancer Res 1998; 18: 77-81. (Pubitemid 28174688)
24. HULL J, THOMSON A, KWIATKOWSKI D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 2000; 55: 1023-1027.
25. OHYAUCHI M, IMATANI A, YONECHI M, et al. The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in Japanese population. Gut 2005; 54: 330-335.
26. JIANG ZD, OKHUYSEN PC, GUO DC, et al. Genetic susceptibility to enteroaggregative Escherichia coli diarrhrrhea: polymorphism in the interleukin-8 promoter region. J Infect Dis 2003; 188: 506-511.
27. ROSS OA, O'NEILL C, REA IM, et al. Functional promoter region polymorphism of the proinflammatory chemokine IL-8 gene associates with Parkinson's disease in the Irish. Hum Immunol 2004; 65: 340-346.
28. MCCARRON SL, EDWARDS S, EVANS PR, et al. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 2002; 62: 3369-3372. (Pubitemid 34651380)
29. RENZONI E, LYMPANY P, SESTINI P, et al. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthritis Rheum 2000; 43: 1633-1640.
30. BARNES PJ. Genetics and pulmonary medicine: 9. Molecular genetics of chronic obstructive pulmonary disease. Thorax 1999; 54: 245-252.
31. KAMALI-SARVESTANI E, GHARESI-FARD B, SARVARI J, et al. Association of TNF-α and TNF-β gene polymorphism with steroid receptor expression in breast cancer patients. Pathol Oncol Res 2005; 11: 99-102. (Pubitemid 41039446)
32. GALEA MH, BLAMEY RW, ELSTON CE, et al.. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 1992; 22: 207-219.
33. MILLER SA, DYKES DD, POLESKY HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
34. GREEN AR, GREEN VL, WHITE MC, et al. Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumours. Int J Cancer 1997; 72: 937-941.
35. AZENSHTEIN E, MESHEL T, SHINA S, et al. The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors. Cancer Lett 2005; 217: 73-86.
36. BEN-BARUCH A. Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Res 2002; 5: 31-36.
37. LANDI S, MORENO V, GIOIA-PATRICOLA L, et al Colorectal Cancer Study Group. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor-α, NFKB1, and peroxisome proliferator-activated receptor-γ with colorectal cancer. Cancer Res 2003; 63: 3560-3566.
38. SMITH KC, BATEMAN AC, FUSSELL HM, et al. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur J Immunogen 2004; 31: 167-173. (Pubitemid 39049861)
39. ROODI N, BAILEY LR, KAO WY, et al. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J Natl Cancer Inst 1995; 15: 446-451.